ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Japan's Tsumura looks to be king of China's herbal medicine market

Drugmaker will leverage the sales network and IT of Chinese insurer Ping An

Medicinal herb growers in China. Japanese drugmaker Tsumura wants to become the No. 1 herbal medicine brand in China.

TOKYO -- Japanese drugmaker Tsumura  plans to capitalize on its partnership with China's Ping An Insurance Group to expand its herbal medicine sales in China to 10 billion yuan ($1.57 billion) by 2027. 

"We aim to become the top brand of traditional Chinese medicine there," Tsumura President Terukazu Kato told reporters in Tokyo on Wednesday.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more